General

EudraVigilance (EV)

Pharmacovigilance

MedDRA

Archive

How do I connect to the EudraVigilance Gateway?

The EudraVigilance Gateway is providing a single point of contact between MAHs, applicants and sponsors as well as Competent Authorities in the EEA. By doing so, the EudraVigilance Gateway is considered a hub and all the connections for the MAH, applicants as well as sponsors and Competent Authorities in the EEA, are known as spokes. Safety and acknowledgement messages are routed through the hub to the desired spoke.

The simplicity of this design allows for the secure transmission of all safety and acknowledgement messages to every participant without the expense and complexity that would be needed to establish a connection between each and every endpoint. The process of establishing the connection requires several steps:

Step 1: Document Transport Choice
The EudraVigilance Gateway supports all popular forms of transport. The most popular form is EDIINT – AS1 or email, followed by AS2 or http and https and finally FTP.

Step 2: Exchange of Profile Information
In order to use the EudraVigilance Gateway for secure document exchange you must provide the EMA with the necessary information in order to create a profile. The EMA in turn will provide the same information to you so that you can create a profile on your system. This information consists of name and address, contact person, and transport details. This information exchange can take place using email.

Step 3: Exchange of Public Keys for Encryption
The EudraVigilance Gateway uses a combination of public/private key encryption, which is also known as asymmetric encryption and symmetric key encryption. This hybrid system uses the best characteristics of each method and minimises the shortcomings of each. It follows the widely adopted S/MIME standard for securing messages.

The EudraVigilance Gateway uses Triple DES encryption and requests that you select a 1024 bit or higher key length to provide enhanced security

Step 4: Testing the connection
When a successful connection has been established, safety and acknowledgement messages, as well as medicinal product report messages, can be transferred between each party in the program. This is accomplished by sending an encrypted safety or acknowledgement message to the EudraVigilance Gateway, where it is unencrypted, checked for basic accuracy, then re-encrypted and sent to the ultimate destination. A list of appropriate registered parties is maintained and distributed by the EMA. It can be also accessed by registered users in the restricted area of the EudraVigilance website. Safety, acknowledgement and medicinal product report message exchange can only take place between registered parties.

During the testing procedure, a series of XML files are sent to the EudraVigilance test environment with paper reports in parallel to assure the correctness of the XML files and compliance with the requested specifications: syntax, field lengths, minimum information and data coding against ICH E2B (R2) and ICH M1 and M2 standard terminology. This will also allow comparison of the submitted data and ensure quality assurance and data consistency. The successful completion of the testing between the EMA and the EDI Partner will be certified by the EMA so that the EDI Partner can move into production pilot. The currently established regulatory reporting mechanism will remain unaffected during the test phase. Details of the 10-sample case can be found in annex 5 of the relevant guideline, which can be downloaded here

This step of the testing is applicable for the testing of all EDI Partners with the EMA. Other EDI Partners may decide to follow the same process.

up | go back
Last update: Tuesday, 19 June 2012.

 

 

News

Help Desk

Training

E-Reporting to Member States

 
Link to EMEA website Link to the EU Commission website